WisdomTree BioRevolution Fund (WDNA)

Description

The investment seeks to track the performance of the N/A. The WDNA ETF contains 114 constituents. It is focused on holdings in the North America region.

Price $16.77 as of 2022-10-20

Cost/Risk/Yield

Dividend yield0.15%
Expense ratio0.45%
Average spread0.894%
1Y roundtrip cost1.344%

Historic prices

Total Returns (including dividends)

Monthly returns heatmap

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022-14.3%-2.6%2.5%-10.9%-1.6%-2.2%9.1%-3.2%-8.1%-0.3%-31.7%
2021-2.9%5.1%-6.4%0.2%-6.2%-1.2%-11.5%
-14.3%-2.6%2.5%-10.9%-1.6%-2.2%6.1%1.9%-14.6%-0.1%-6.2%-1.2%

Historical Dividends

Monthly dividend heatmap

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
20210.030.03
0.000.000.000.000.000.000.000.000.000.000.000.03

Sectors and Top Holdings

Security % Assets
Astrazeneca PLC Sponsored ADR2.00%
Repligen Corporation1.70%
PerkinElmer, Inc.1.57%
Eli Lilly and Company1.57%
Thermo Fisher Scientific Inc.1.56%
Vitrolife AB1.47%
Zoetis, Inc. Class A1.42%
VERBIO Vereinigte BioEnergie AG1.42%
Catalent Inc1.41%
Danaher Corporation1.41%
Moderna, Inc.1.39%
Bio-Techne Corporation1.38%
Darling Ingredients Inc.1.38%
BioNTech SE Sponsored ADR1.37%
Agilent Technologies, Inc.1.36%
Top 15 Weights22.41%

Compare with similar ETFs

WDNA GNOM HTEC IBBQ PBE PTH
Product nameWisdomTree BioRevolution FundGlobal X Genomics & Biotechnology ETFROBO Global Healthcare Technology and Innovation ETFInvesco Nasdaq Biotechnology ETFPowerShares Dynamic Biotechnology & Genome Portfolio ETFPowerShares DWA Healthcare Momentum Portfolio ETF
IssuerWisdomTreeGlobal XROBO GlobalInvescoInvescoInvesco
Price$16.773$12.1069$26.5$18.95$59.39$119.35
Expense Ratio0.45%worse0.5%worse0.68%0%worse0.59%worse0.6%
Average Spread0.894%0.330%0.000%0.211%0.253%0.251%
AUM$0$148,703,000$134,262,000$33,791,400$226,683,000$345,192,000
Shares012,282,4605,066,4981,783,1893,816,8542,892,267
Average Daily Volume41088,58611,2308,1928,7437,753
Home pageVisit external siteVisit external siteVisit external siteVisit external siteVisit external site
Inception Date2021-06-032019-04-052019-06-252021-06-112005-06-232006-10-12
Index TrackedN/ASolactive Genomics IndexNASDAQ Biotechnology IndexDynamic Biotechnology & Genome Intellidex IndexDWA Healthcare Technical Leaders Index
CategoryHealth & Biotech EquitiesHealth & Biotech EquitiesHealth & Biotech Equitiesn/aHealth & Biotech EquitiesHealth & Biotech Equities
Asset ClassEquityEquityEquityEquityEquityEquity
Asset Class SizeLarge/Mid/Small CapsLarge/Mid CapsLarge/Mid CapsLarge/Mid/Small CapsLarge/Mid/Small Caps
Value or GrowthGrowthGrowthGrowthGrowth
RegionNorth AmericaNorth AmericaNorth AmericaNorth AmericaNorth America
CountriesBroadU.S.U.S.U.S.U.S.U.S.
Annual Dividend Rate$0.025$0.007$0.023$0.224$0$0
Annual Dividend Yield0.001%0.001%0.001%0.012%0.000%0.000%
Number of Holdings114402683055
YTD Return-29.05%-39.01%-39.18%-19.61%-16.60%-22.98%
Beta0.980.900.970.951.221.17
Upside Beta-1.100.110.32-1.230.120.22
Downside Beta-1.20-0.27-0.06-1.220.09-0.18
Volatility 1Y28.82%45.00%33.88%28.75%30.04%27.79%
Sharpe Ratio 3Y0.00-0.150.130.000.310.80
Treynor Ratio 3Y0.000.000.000.000.000.01

Historic volatility

Implied volatility

Put/Call Ratio (option volume)

Put/Call Ratio (open interest)

Volatility Spread

Volatility Skew